These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11935935)

  • 1. Resorbable polymeric sponges as drug carriers. Part 2. Gelatin sponge.
    Pluta J; Haznar D
    Polim Med; 2001; 31(3-4):16-24. PubMed ID: 11935935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of composition upon the physical and chemical properties of biodegradable gelatin polymer matrixes.
    Pluta J; Haznar D
    Polim Med; 2002; 32(3-4):11-9. PubMed ID: 12677647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resorbed polymeric sponge used as a carrier the therapeutic substance. Part 1. Gelatine sponge.
    Pluta J; Haznar D
    Polim Med; 2001; 31(1-2):18-25. PubMed ID: 11712197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of vancomycin from multilayer coated absorbent gelatin sponges.
    Shukla A; Fang JC; Puranam S; Hammond PT
    J Control Release; 2012 Jan; 157(1):64-71. PubMed ID: 21939701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of the gelatin-alginate matrixes with calcium lactate in plasma coagulation system after implantation in soft tissues].
    Szymonowicz M; Zywicka B; Rybak Z; Rusak A; Haznar D; Pluta J
    Polim Med; 2013; 43(3):159-64. PubMed ID: 24377182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of vancomycin and teicoplanin from a plasticized and resorbable gelatin sponge: in vitro investigation of a new antibiotic delivery system with glycopeptides.
    Drognitz O; Thorn D; Krüger T; Gatermann SG; Iven H; Bruch HP; Muhl E
    Infection; 2006 Feb; 34(1):29-34. PubMed ID: 16501900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemostasis with resorbable fibrin sponges].
    Duloquin MM; Vitenberg
    Inf Dent; 1966 May; 48(19):2046-8. PubMed ID: 5218997
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetracycline release from tripolyphosphate-chitosan cross-linked sponge: a preliminary in vitro study.
    Shen EC; Wang C; Fu E; Chiang CY; Chen TT; Nieh S
    J Periodontal Res; 2008 Dec; 43(6):642-8. PubMed ID: 18624950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteogenesis in a rat model: use of bone marrow cells and biodegradable gelatin matrix carrier.
    Troum S; Dalton ML
    J South Orthop Assoc; 2001; 10(1):37-43. PubMed ID: 12132841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic gelatin sponge tract injection to prevent bleeding after percutaneous renal cryoablation in a swine model.
    Permpongkosol S; Nicol TL; Bagga HS; Kohanim S; Kavoussi L; Solomon SB
    J Vasc Interv Radiol; 2006 Sep; 17(9):1505-9. PubMed ID: 16990471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of hybrid scaffold from fibrin and biodegradable polymer fiber.
    Hokugo A; Takamoto T; Tabata Y
    Biomaterials; 2006 Jan; 27(1):61-7. PubMed ID: 16000222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and beta-tricalcium phosphate.
    Takahashi Y; Yamamoto M; Tabata Y
    Biomaterials; 2005 Jun; 26(17):3587-96. PubMed ID: 15621249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The size of gelatin sponge particles: differences with preparation method.
    Katsumori T; Kasahara T
    Cardiovasc Intervent Radiol; 2006; 29(6):1077-83. PubMed ID: 16967213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate.
    Takahashi Y; Yamamoto M; Tabata Y
    Biomaterials; 2005 Aug; 26(23):4856-65. PubMed ID: 15763265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal experimental studies on the biocompatibility of resorbable gelatin sponges and dry fibrin foam].
    Streckbein RG; Lorber CG
    Dtsch Zahnarztl Z; 1978 Oct; 33(10):685-8. PubMed ID: 280448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of gelatin-alginian matrixes on morphological and functional changes of blood leukocytes].
    Pliszczak-Król A; Szymonowicz M; Król J; Rybak Z; Graczyk S; Haznar D; Pluta J
    Polim Med; 2013; 43(3):153-8. PubMed ID: 24377181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Healing of internal organs with the use of Polish-made hemostatic gelatin-starch sponges].
    Pruszczyński M; Szmigielska H; Mikucka B
    Polim Med; 1977; 7(2):119-28. PubMed ID: 600883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a galactose-carrying gelatin sponge for hepatocytes culture and transplantation.
    Hong SR; Lee YM; Akaike T
    J Biomed Mater Res A; 2003 Dec; 67(3):733-41. PubMed ID: 14613220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tuberculoid tissue reactions following implantation of a resorbable gelatin preparation].
    Aderhold L; Frenkel G
    Quintessenz; 1986 Sep; 37(9):1581-5. PubMed ID: 3538120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.